Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome
Sara Cherry, Kristen W. Lynch
Genes & Development (2020) Vol. 34, Iss. 15-16, pp. 1005-1016
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities
Paz Nombela, Borja Miguel‐López, Sandra Blanco
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 356
The physiology of alternative splicing
Luciano E. Marasco, Alberto R. Kornblihtt
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 4, pp. 242-254
Closed Access | Times Cited: 255
The pancreatic cancer genome revisited
Akimasa Hayashi, Jungeui Hong, Christine A. Iacobuzio‐Donahue
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 7, pp. 469-481
Closed Access | Times Cited: 156
ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data
Yuan Gao, Feng Wang, Robert Wang, et al.
Science Advances (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 49
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Xuemei Lv, Xiaoyu Sun, Yang Gao, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Pingping Ren, Luying Lu, Shasha Cai, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing
Yang Pan, John W. Phillips, Beatrice Zhang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 31
RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets
Yang Pan, Kathryn E. Kadash-Edmondson, Robert Wang, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 268-282
Open Access | Times Cited: 53
Arsenic-induced epigenetic changes in cancer development
Wesley N. Saintilnord, Yvonne Fondufe‐Mittendorf
Seminars in Cancer Biology (2021) Vol. 76, pp. 195-205
Open Access | Times Cited: 43
RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma
Jonas Weiße, Julia Rosemann, Vanessa Krauspe, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6835-6835
Open Access | Times Cited: 42
Computing the Role of Alternative Splicing in Cancer
Zhaoqi Liu, Raúl Rabadán
Trends in cancer (2021) Vol. 7, Iss. 4, pp. 347-358
Open Access | Times Cited: 39
Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia
Osvaldo D. Rivera, Michael J. Mallory, Mathieu Quesnel-Vallières, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 15
Open Access | Times Cited: 34
Epigenetic Dysregulations in Arsenic-Induced Carcinogenesis
Ranakul Islam, Lei Zhao, Yi-Fang Wang, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4502-4502
Open Access | Times Cited: 26
Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities
Akila S. Venkataramany, Kathleen M. Schieffer, K Lee, et al.
Annals of Oncology (2022) Vol. 33, Iss. 6, pp. 578-592
Open Access | Times Cited: 25
DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1
Haonan Zhang, Chengcheng He, Xuxue Guo, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 23
CPEB2 m6A methylation regulates blood–tumor barrier permeability by regulating splicing factor SRSF5 stability
Mengyang Zhang, Chunqing Yang, Xuelei Ruan, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Alternative RNA splicing in tumour heterogeneity, plasticity and therapy
Sebastian Pohl, Kevin Myant
Disease Models & Mechanisms (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer
Jian Han, Ömer An, Xi Ren, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis
Hong Wang, Dong Qian, Jiabei Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CML
Reinhard Brunmeir, Ying Li, Junli Yan, et al.
Leukemia (2025)
Open Access
Cyperotundone promotes chemosensitivity of breast cancer via SRSF1
Chao Li, Lin Wang, Zhaoyun Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT
Weixiong Zheng, Yongfeng Shang, Kai Du, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2025), pp. 1-10
Closed Access
N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis
Zhenyu Zhao, Qidong Cai, Pengfei Zhang, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 26
Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer
Weihua Li, Rui Wan, Lei Guo, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Re-appraising the evidence for the source, regulation and function of p53-family isoforms
Ignacio López, Irene Larghero Valdivia, Bořivoj Vojtěšek, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 20, pp. 12112-12129
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top